Investor

TF Capital (Shanghai)

TF Capital is a Shanghai-based investor backing early-stage biotech companies in China

Write a review

Management
Science
Shanghai

Visit Website Get introducedRequest an introduction Write a Review

Own this listing? Claim it

TrustList summary

TF Capital is a Chinese investment firm that describes itself as an early investor in biotechnology companies, working with founders from the earliest stages of a company's development. It provides capital alongside what it calls value-chain support, drawing on relationships across the biopharmaceutical industry, including listed companies, clinical experts and other investment funds. The firm reports managing a substantial amount of assets, and says its portfolio has generated a large sum in upfront licence-out payments from a number of deals across several companies over five consecutive years with multinational pharmaceutical partners. It also says more than 20 of its portfolio companies have completed initial public offerings, with a further 15 or more in IPO filing.

Summary written by TrustList from the business's own published information, Sep 2026.

Gallery

2 images - click to enlarge

Categories & features

Management
Science
Shanghai

Rankings

TF Capital (Shanghai) is ranked on 1 TrustList ranking at #33.

Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. TF Capital (Shanghai) has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.

Investor · 1 ranking

#33of 35
Shanghai
It is one of 4 here listing science.
Its profile: “TF Capital is a Shanghai-based investor backing early-stage biotech companies in China”
Of the 35 here, 5 also cover healthtech and 5 also cover biotech; 16 also work in Hong Kong and 15 also work in Beijing.
Behind Sky9 Capital, ahead of Tsai Capital Corporation.

As of 2026-11-02. Organic ranks only; sponsored placements are never ranks. How TrustList ranks